ORIGINAL RESEARCH
Accepted on 24 Nov 2025
- Frontiers in Immunology
- Inflammation
- Research Topics
- Evolving paradigms: IL-5's role in eosinophilic pathologies and targeted treatments
Evolving paradigms: IL-5's role in eosinophilic pathologies and targeted treatments
114
Total downloads
4,776
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 19 Nov 2025
From hypereosinophilia to hypereosinophilic syndrome (HES): real-world application of a two-tailed approach for HES diagnosis
CASE REPORT
Published on 17 Nov 2025
Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: Benralizumab
doi 10.3389/fimmu.2025.1720992
- 998 views
REVIEW
Published on 14 Nov 2025
Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence
doi 10.3389/fimmu.2025.1704077
- 950 views
ORIGINAL RESEARCH
Published on 23 Oct 2025
Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center study
doi 10.3389/fimmu.2025.1702989
- 948 views
Published in
Frontiers in Immunology
Inflammation
Other participating journals
Frontiers in Medicine
- 3.0 impact factor
- 6.0 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: